Cargando…
P4 COVID19-associated fungal infections
PLENARY SESSION 4, SEPTEMBER 22, 2022, 2:00 PM - 2:45 PM: : Coronavirus disease 2019 (COVID-2019) associated invasive fungal infections (IFIs) have emerged as an important complication in a substantial number of critically ill COVID-19 patients, and three groups of fungal pathogens have increasin...
Autor principal: | Hoenigl, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494467/ http://dx.doi.org/10.1093/mmy/myac072.P4 |
Ejemplares similares
-
S4.1a Fusariosis: MICs, mono versus combination therapy and fosmanogepix
por: Hoenigl, Martin
Publicado: (2022) -
P133 Post-COVID-19 recurrent fungal urinary tract infections: A case series
por: Shetty, Siddhant, et al.
Publicado: (2022) -
P266 A case of mixed fungal infection causing invasive fungal Rhinosinusitis in a post-COVID patient
por: Ray, Ujjwayini, et al.
Publicado: (2022) -
P482 Burden of serious fungal infections in India
por: Ray, Animesh, et al.
Publicado: (2022) -
P492 Invasive fungal infection during COVID era at tertiary care hospital
por: Seema, Kumari, et al.
Publicado: (2022)